|
RNF111 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.66179999445171E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5321899999976E-05 |
| Normal-vs-Stage2 |
1.822230E-04 |
| Normal-vs-Stage3 |
4.15590000191202E-08 |
| Normal-vs-Stage4 |
1.71389999970017E-08 |
| Stage1-vs-Stage2 |
5.411200E-01 |
| Stage1-vs-Stage3 |
7.787800E-02 |
| Stage1-vs-Stage4 |
1.853670E-02 |
| Stage2-vs-Stage3 |
5.383600E-01 |
| Stage2-vs-Stage4 |
1.811630E-01 |
| Stage3-vs-Stage4 |
3.142000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.35039999960007E-07 |
| Normal-vs-AfricanAmerican |
2.269800E-02 |
| Normal-vs-Asian |
8.07140000000928E-05 |
| Caucasian-vs-AfricanAmerican |
2.748800E-01 |
| Caucasian-vs-Asian |
9.728800E-01 |
| AfricanAmerican-vs-Asian |
3.386400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.59530000110442E-09 |
| Normal-vs-Female |
1.20410000004068E-06 |
| Male-vs-Female |
1.001150E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.26949999999815E-05 |
| Normal-vs-Age(41-60Yrs) |
8.38890000021131E-07 |
| Normal-vs-Age(61-80Yrs) |
2.07429999843356E-08 |
| Normal-vs-Age(81-100Yrs) |
2.755800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.634000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.214100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.026600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.376200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.172000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.163400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.094300E-02 |
| Classical-VS-Follicular |
2.216000E-03 |
| Classical-VS-Other |
2.298400E-01 |
| Classical-VS-Normal |
2.39380000000011E-05 |
| Tall-VS-Follicular |
9.309000E-01 |
| Tall-VS-Other |
9.112400E-01 |
| Tall-VS-Normal |
2.02279999994559E-06 |
| Follicular-VS-Other |
9.006200E-01 |
| Follicular-VS-Normal |
1.87229999948357E-07 |
| Other-VS-Normal |
7.842500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.2368000003078E-07 |
| Normal-vs-N1 |
8.31259999944933E-07 |
| N0-vs-N1 |
3.548800E-01 |
|
|
